Kathryn Wheeler
Associate Dean & Associate Clinical Professor/Pharmacy

Are you Kathryn Wheeler?

How to update your information.
FDA approves novel topical therapy for molluscum contagiosum
2024
Kathryn Wheeler, Shelly Evia
Research Type: Journal Article

A novel approach to pharmacy law instruction.
2021
Jill Fitzgerald, Lisa Holle, Kathryn Wheeler, Matthew Deneff
Research Type: Journal Article

Ubrogepant: A Novel Drug Mechanism For Migraine Treatment
2020
Research Type: Journal Article

Lumateprone Tosylate Approved For Schizophrenia
2020
Elefterios Hamilakis, Kathryn Wheeler
Research Type: Journal Article

Barhemsys (Amisulpride) for Postoperative Nausea and Vomiting
2020
John Kassis, Kathryn Wheeler
Research Type: Journal Article

Prucalopride Approved for Idiopathic Constipation
2019
Research Type: Journal Article

New Drug Review: Zulresso (Brexanolone)
2019
Research Type: Journal Article

Prucalopride approved for idiopathic constipation
2019
Research Type: Journal Article

NDR: Dsuvia (Sufentanil) for Acute Refractory Pain
2019
Kathryn Wheeler, Alison Geary
Research Type: Journal Article

Ibalizumab-uiyk (Trogarzo) for multi-drug resistant HIV-1
2018
Research Type: Journal Article

First in class drug for glaucoma: What pharmacists need to know
2018
Research Type: Journal Article

Plecanatide: Approved for Chronic Idiopathic Constipation
2017
Research Type: Journal Article

Kevzara (Sarilumab); New drug treatment for Rheumatoid Arthritis
2017
Research Type: Journal Article

Sugammadex: The First Selective Relaxant Binding Agent
2017
Research Type: Journal Article

Neratinib for early stage breast cancer
2017
Research Type: Journal Article

Dual therapies for COPD: The scientific rationale for LAMA and LABA
2016
Research Type: Journal Article

New adjunctive medication for eosinophilic asthma
2016
Research Type: Journal Article

New drug approved for gout maintenance therapy
2016
Research Type: Journal Article

Long term safety of glycopyrrolate: A randomized study of COPD patients
2016
Research Type: Journal Article

FDA approves new Pradaxa reversal agent
2016
Research Type: Journal Article